PureTech Health plc (PTCHF)
USD 1.75
(-5.91%)
USD 1.75
(-5.91%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -65.69 Million USD | -77.25% |
| 2022 | -37.06 Million USD | 40.9% |
| 2021 | -62.7 Million USD | -1472.79% |
| 2020 | 4.56 Million USD | -98.92% |
| 2019 | 421.14 Million USD | 1064.73% |
| 2018 | -43.65 Million USD | -241.42% |
| 2017 | 30.86 Million USD | 163.27% |
| 2016 | -48.79 Million USD | -23.86% |
| 2015 | -39.39 Million USD | 5.4% |
| 2014 | -41.64 Million USD | -867.77% |
| 2013 | -4.3 Million USD | 61.07% |
| 2012 | -11.05 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -20.88 Million USD | 0.0% |
| 2024 Q1 | -20.88 Million USD | 48.26% |
| 2023 Q2 | -25 Million USD | -100.01% |
| 2023 Q1 | -12.5 Million USD | 45.85% |
| 2023 FY | -65.69 Million USD | -77.25% |
| 2023 Q4 | -40.36 Million USD | -98.41% |
| 2023 Q3 | -20.34 Million USD | 18.63% |
| 2022 Q4 | -23.08 Million USD | -109.8% |
| 2022 Q2 | -28.34 Million USD | -100.0% |
| 2022 Q3 | -11 Million USD | 61.17% |
| 2022 FY | -37.06 Million USD | 40.9% |
| 2022 Q1 | -14.17 Million USD | -194.64% |
| 2021 FY | -62.7 Million USD | -1472.79% |
| 2021 Q2 | -75.39 Million USD | -100.0% |
| 2021 Q4 | 14.97 Million USD | 101.86% |
| 2021 Q3 | 7.41 Million USD | 109.84% |
| 2021 Q1 | -37.69 Million USD | 67.46% |
| 2020 FY | 4.56 Million USD | -98.92% |
| 2020 Q2 | 61.97 Million USD | 0.0% |
| 2020 Q3 | -58.98 Million USD | -195.17% |
| 2020 Q4 | -115.85 Million USD | -96.42% |
| 2020 Q1 | 61.97 Million USD | -84.43% |
| 2019 FY | 421.14 Million USD | 1064.73% |
| 2019 Q3 | 173.81 Million USD | 513.29% |
| 2019 Q4 | 398.08 Million USD | 129.02% |
| 2019 Q2 | 28.34 Million USD | -22.89% |
| 2019 Q1 | 36.75 Million USD | 302.28% |
| 2018 Q4 | -18.16 Million USD | 0.0% |
| 2018 FY | -43.65 Million USD | -241.42% |
| 2018 Q2 | -3.65 Million USD | 0.0% |
| 2018 Q1 | -3.65 Million USD | -110.65% |
| 2018 Q3 | -18.16 Million USD | -396.77% |
| 2017 Q3 | 34.33 Million USD | 262.74% |
| 2017 Q1 | -21.09 Million USD | -124.57% |
| 2017 Q2 | -21.09 Million USD | 0.0% |
| 2017 FY | 30.86 Million USD | 163.27% |
| 2017 Q4 | 34.33 Million USD | 0.0% |
| 2016 Q2 | -15 Million USD | 0.0% |
| 2016 FY | -48.79 Million USD | -23.86% |
| 2016 Q1 | -15 Million USD | -1.75% |
| 2016 Q4 | -9.39 Million USD | 0.0% |
| 2016 Q3 | -9.39 Million USD | 37.38% |
| 2015 Q3 | -14.74 Million USD | -197.71% |
| 2015 Q1 | -4.95 Million USD | 60.76% |
| 2015 FY | -39.39 Million USD | 5.4% |
| 2015 Q4 | -14.74 Million USD | 0.0% |
| 2015 Q2 | -4.95 Million USD | 0.0% |
| 2014 Q2 | -8.19 Million USD | 0.0% |
| 2014 Q4 | -12.62 Million USD | 0.0% |
| 2014 Q1 | -8.19 Million USD | 0.0% |
| 2014 FY | -41.64 Million USD | -867.77% |
| 2014 Q3 | -12.62 Million USD | -53.95% |
| 2013 FY | -4.3 Million USD | 61.07% |
| 2012 FY | -11.05 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -4819.535% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -840.836% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 224.006% |
| Nascent Biotech, Inc. | -2.08 Million USD | -3046.887% |
| Rebus Holdings, Inc. | -1.02 Million USD | -6340.882% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 200.866% |
| Qrons Inc. | -789.34 Thousand USD | -8222.956% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -10288.405% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -4.949% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -15712.352% |
| Skye Bioscience, Inc. | -37.64 Million USD | -74.518% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 12.361% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -899.025% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -23929.451% |
| SQZ Biotechnologies Company | -79.46 Million USD | 17.325% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -2171.371% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -3508.678% |
| Mesoblast Limited | -87.95 Million USD | 25.307% |
| Marizyme, Inc. | -65.34 Million USD | -0.536% |
| Genus plc | 7.9 Million USD | 931.608% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -503.182% |
| Pharming Group N.V. | -10.54 Million USD | -522.838% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -2927.771% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -1670.697% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -642.843% |
| ContraFect Corporation | -65.15 Million USD | -0.835% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -1244.579% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -3703.109% |
| IMV Inc. | -36.48 Million USD | -80.062% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -715.131% |
| MultiCell Technologies, Inc. | -380.07 USD | -17285400.039% |
| ONE Bio Corp. | 8.67 Million USD | 857.173% |
| Accustem Sciences Inc. | -3.74 Million USD | -1653.595% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -27.093% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -5084.692% |
| Q BioMed Inc. | -2.05 Million USD | -3101.463% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -1659.898% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -2659.369% |
| Biomind Labs Inc. | -1.21 Million USD | -5310.193% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -9.998% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -2018.05% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -731.282% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -3270.375% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -438581.891% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -313.932% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -1029.347% |
| GB Sciences, Inc. | -1.36 Million USD | -4724.712% |
| Alpha Cognition Inc. | -13.77 Million USD | -377.013% |
| HST Global, Inc. | -146.21 Thousand USD | -44833.315% |
| CSL Limited | 2.64 Billion USD | 102.487% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -3643.907% |
| Halberd Corporation | -79.67 Thousand USD | -82355.194% |
| Enzolytics Inc. | -2.17 Million USD | -2918.01% |
| Agentix Corp. | -1.37 Million USD | -4680.707% |
| Resverlogix Corp. | -3.61 Million USD | -1719.861% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -1971.522% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 77.734% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 67137.755% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 1048.749% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -1553.59% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -2070.987% |
| AVAX Technologies, Inc. | -6.41 Million USD | -924.331% |
| Zenith Capital Corp. | -10.59 Million USD | -520.017% |
| Genscript Biotech Corporation | -95.47 Million USD | 31.191% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -282565.003% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -1484.612% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -108596.785% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -3176.47% |
| Kadimastem Ltd | -3.3 Million USD | -1886.365% |
| Helix BioMedix, Inc. | -1.05 Million USD | -6120.971% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -1620.267% |
| BioStem Technologies, Inc. | -8.48 Million USD | -674.456% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -14784.824% |
| LadRx Corporation | 400.44 Thousand USD | 16506.08% |
| Cell Source, Inc. | -5.32 Million USD | -1134.625% |
| Regen BioPharma, Inc. | 1.02 Million USD | 6518.807% |
| Regen BioPharma, Inc. | 1.02 Million USD | 6518.807% |
| NovAccess Global Inc. | -4.76 Million USD | -1277.53% |
| Affymax, Inc. | -14.42 Million USD | -355.47% |
| Itoco Inc. | -1.86 Million USD | -3415.098% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -1378.818% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -3836.309% |
| Mobile Lads Corp. | -2.26 Million USD | -2802.719% |
| CytoDyn Inc. | -49.84 Million USD | -31.813% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -83026.036% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -28698.432% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -6877.693% |
| SYBLEU INC | -180.3 Thousand USD | -36336.796% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -3973.634% |
| International Stem Cell Corporation | -131 Thousand USD | -50050.382% |
| Bioxytran, Inc. | -4.28 Million USD | -1434.976% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -120951.371% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -2496.466% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -36.664% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -3007.711% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -8313.125% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -1973.769% |
| Neutra Corp. | -233.46 Thousand USD | -28039.978% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -223.774% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -208.922% |
| IXICO plc | -1.17 Million USD | -5476.995% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -561.801% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -15.0% |
| CSL Limited | 2.64 Billion USD | 102.487% |
| Cellectis S.A. | -103.17 Million USD | 36.324% |